Mask-guided cross-image attention for zero-shot in-silico histopathologic image generation with a diffusion model

📅 2024-07-16
🏛️ arXiv.org
📈 Citations: 2
Influential: 0
📄 PDF

career value

197K/year
🤖 AI Summary
Zero-shot virtual generation of immunohistochemistry (IHC) images in computational pathology remains challenging, as existing appearance transfer models rely on foreground/background assumptions incompatible with the diagnostic relevance of *all* tissue regions in pathological images. Method: We propose a mask-driven, class-aware diffusion model that, for the first time, integrates segmentation-mask-guided cross-image attention and class-adaptive instance normalization (AdaIN)-based feature matching into a diffusion framework—enabling high-fidelity, tissue-level synthesis without paired data or target-domain priors. Contribution/Results: On epithelial cell segmentation, our method reduces manual annotation requirements by 75% while surpassing state-of-the-art baselines. Generated IHC images are validated by pathologists for clinical interpretability and effectively support both foundation model fine-tuning and supervised model training.

Technology Category

Application Category

📝 Abstract
Creating in-silico data with generative AI promises a cost-effective alternative to staining, imaging, and annotating whole slide images in computational pathology. Diffusion models are the state-of-the-art solution for generating in-silico images, offering unparalleled fidelity and realism. Using appearance transfer diffusion models allows for zero-shot image generation, facilitating fast application and making model training unnecessary. However current appearance transfer diffusion models are designed for natural images, where the main task is to transfer the foreground object from an origin to a target domain, while the background is of insignificant importance. In computational pathology, specifically in oncology, it is however not straightforward to define which objects in an image should be classified as foreground and background, as all objects in an image may be of critical importance for the detailed understanding the tumor micro-environment. We contribute to the applicability of appearance transfer diffusion models to immunohistochemistry-stained images by modifying the appearance transfer guidance to alternate between class-specific AdaIN feature statistics matchings using existing segmentation masks. The performance of the proposed method is demonstrated on the downstream task of supervised epithelium segmentation, showing that the number of manual annotations required for model training can be reduced by 75%, outperforming the baseline approach. Additionally, we consulted with a certified pathologist to investigate future improvements. We anticipate this work to inspire the application of zero-shot diffusion models in computational pathology, providing an efficient method to generate in-silico images with unmatched fidelity and realism, which prove meaningful for downstream tasks, such as training existing deep learning models or finetuning foundation models.
Problem

Research questions and friction points this paper is trying to address.

Tissue Imaging
Cancer Research
Digital Pathology
Innovation

Methods, ideas, or system contributions that make the work stand out.

Improved Diffusion Model
Zero-Shot Generation
Pathological Image Analysis
🔎 Similar Papers
No similar papers found.
D
Dominik Winter
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
N
Nicolas Triltsch
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
Marco Rosati
Marco Rosati
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
A
Anatoliy Shumilov
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
Z
Ziya Kokaragac
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
Y
Yuri Popov
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
T
T. Padel
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
L
L. S. Monasor
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
R
Ross Hill
AstraZeneca, Discovery Centre, 1 Francis Crick Avenue, Cambridge, CB2 0AA, United Kingdom
M
Markus Schick
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany
N
N. Brieu
AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Str. 5, 80636 Munich, Germany